| chloratranol |
F3 |
strong |
LLNA EC3 = 0.4%, pEC3 = 2.67 |
(1) low Gly-pNA imine stability
(log K < 2, Table 1) |
| (2) lowest imine
decomposition rates (k–1pseudo < 0.005 min–1, Table 1) |
| (3) cross-linking
of protein structures (Scheme 8) |
| human potency class
1 |
(4) adduct stabilization through imine-enaminone tautomerisation11
|
| (5) high lysine reactivity
at pH 7.511 (Table 2) |
| (6) high cysteine-SH
reactivity39
|
| atranol |
F2 |
strong |
LLNA EC3 = 0.6%, pEC3 = 2.40 |
(1) low Gly-pNA
imine stability (log K < 2, Table 1) |
| (2)
lowest imine decomposition rates (k–1pseudo < 0.004 min–1, Table 1) |
| (3) cross-linking of protein structures (Scheme 8, Natsch & Emter 201732) |
| human potency class 1 |
(4) adduct
stabilization through imine-enaminone tautomerization11
|
| (5) high lysine reactivity at
pH 7.511 (Table 2) |
| (6) high cysteine-SH
reactivity39
|
| 2-bromo-5-hydroxy benzaldehyde |
E4 |
moderate |
LLNA EC3 = 2.6%, pEC3 = 1.89 |
(1) medium Gly-pNA imine stability (log K > 2, Table 1) |
| (2) no lysine reactivity at pH 7.511 (Table 2) |
| (3) SNAr-type adduct formation
with cysteine-SH
(Scheme 10) |
| 4-chlorobenzaldehyde |
D2 |
weak/non |
LLNA EC3 > 10%, pEC3 < 1.15 |
(1) low Gly-pNA imine stability (log K < 2, Table 1) |
| (2) moderate lysine reactivity
at pH 7.511 (Table 2) |
| 4-isopropyl
benzaldehyde |
B1 |
weak/non |
LLNA EC3 > 10%, pEC3 <1.17 |
(1) very low Gly-pNA
imine stability (log K < 1, Table 1) |
| (2)
low lysine reactivity at pH 7.511 (Table 2) |
| 4-methyl benzaldehyde |
A4 |
weak/non |
LLNA EC3 > 10% (0.69%) |
(1) very low Gly-pNA
imine stability (log K < 1, Table 1) |
| pEC3 <1.08 (2.24) |
(2) very low lysine
reactivity at pH 7.511 (Table 2) |
| 6-methoxy naphthalene carbaldehyde |
F1 |
weak/non |
LLNA EC3 > 20%, pEC3 <1.17 |
(1) low Gly-pNA imine stability (log K < 2, Table 1) |
| (2) no lysine reactivity at pH
7.511 (Table 2) |
| benzaldehyde |
A1 |
weak/non |
LLNA EC3 > 25%, pEC3 < 0.63 |
(1) low Gly-pNA imine stability (log K < 2, Table 1) |
| human potency class 5 |
(2) very low lysine reactivity at pH 7.511 (Table 2) |
| LOEL 2760 μg/cm2
|
| NOEL 590 μg/cm2
|
| 4-hydroxy benzaldehyde |
B4 |
weak/non |
LLNA EC3 > 25%, pEC3 < 0.69 |
(1)
very low Gly-pNA imine stability (log K <
0, Table 1) |
| (2) no lysine reactivity at pH 7.511 (Table 2) |
| 4-methoxy benzaldehyde |
C3 |
weak/non |
LLNA EC3 > 25%, pEC3 < 0.74 |
(1) very low Gly-pNA imine stability (log K < 1, Table 1) |
| LOEL 4724 μg/cm2
|
(2) no lysine
reactivity at pH 7.511 (Table 2) |
| NOEL-HRIPT 3543 μg/cm2
|
| NOEL-HPT 6900 μg/cm2
|
| 4-nitro benzaldehyde |
D1 |
weak/non |
LLNA EC3 > 50%, pEC3 < 0.48 |
(1) medium Gly-pNA imine stability (log K > 2, Table 1) |
| (2) no lysine reactivity at pH
7.511 (Table 2) |
| vanillin |
D3 |
weak/non |
LLNA EC3 > 50%, pEC3 < 0.48 |
(1) very low Gly-pNA imine stability (log K < 0, Table 1) |
| human potency class 5 |
(2) very low lysine reactivity at pH 7.511 (Table 2) |
| NOEL 1181 μg/cm2
|
| ethyl
vanillin |
D4 |
weak/non |
LLNA EC3 > 50%, pEC3 < 0.52 |
(1) very low Gly-pNA
imine stability (log K < 0, Table 1) |
| (2)
very low lysine reactivity at pH 7.511 (Table 2) |
| 3-chloro-4-methoxy benzaldehyde |
E3 |
weak/non |
LLNA EC3 > 65%, pEC3 < 0.42 |
(1) very low Gly-pNA imine stability (log K < 1, Table 1) |
| (2) very low lysine reactivity
at pH 7.511 (Table 2) |
| 2-hydroxy
benzaldehyde |
B2 |
-- |
positive in human tests |
(1) very low Gly-pNA adduct stability (log K < 1, Table 1) |
| (2) moderate lysine reactivity at pH 7.511 (Table 2) |